Patent Assignment
Reel/Frame 050000/0762
Release of Security Interest
Recorded: 2019-08-08
Pages: 6
Assignor
VICTORY PARK MANAGEMENT, LLC
Executed: 2013-04-25
Assignee
UNIGENE LABORATORIES, INC.
110 LITTLE FALLS ROAD, FAIRFIELD, NEW JERSEY, 07004
Covered Properties
(28)
Alpha-Amidating Enzyme Compositions and Processes for Their Production and Use
Patent:
6,319,685 →
Application:
07/086,161 →
Expression Systems for Amidating Enzyme
Patent:
5,789,234 →
Application:
07/307,366 →
Oral Salmon Calcitonin Pharmaceutical Products
Patent:
5,912,014 →
Application:
08/616,250 →
Direct Expression of Peptides into Culture Media
Patent:
6,103,495 →
Application:
09/060,765 →
Oral Peptide Pharmaceutical Products
Patent:
6,086,918 →
Application:
09/125,500 →
Direct expression of peptides into culture media
Patent:
6,210,925 →
Application:
09/500,009 →
Nasal Calcitonin Formulations
Patent:
6,440,392 →
Application:
09/776,537 →
Direct Expression of Peptides into Culture Media
Direct Expression of Peptides into Culture Media
Oral Delivery of Peptides Using Enzyme-Cleavable Membrane Translocators
Oral Peptide Pharmaceutical Dosage Form and Method of Production
Hybrid Molds for Molten Solder Screening Process
Oral Delivery of Peptides
Nasal Calcitonin Formulation
Patent:
40,812 →
Application:
10/774,358 →
Direct Expression of Peptides into Culture Media
Amidated parathyroid hormone fragments and uses thereof
Application:
11/040,557 →
Publication:
US 2005/0215476
Bacterial Host Cell for the Direct Expression of Peptides
Enzymatic Reactions in the Presence of Keto Acids
Amidated parathyroid hormone fragments and uses thereof
Application:
11/455,628 →
Publication:
US 2006/0270603
Cell lines for expressing enzyme useful in the preparation of amidated products
Fast-Acting Oral Peptide Pharmaceutical Products
Method for Detecting the Presence of Glycine Containing Compounds
Application:
11/654,211 →
Publication:
US 2007/0254328
Bacterial Host Cell for the Direct Expression of Peptides
Bacterial Host Cell for the Direct Expression of Peptides
Bacterial Host Cell for the Direct Expression of Peptides
Bacterial Host Cell for the Direct Expression of Peptides
Peptide Pharmaceutical for Oral Delivery
Peptide Pharmaceutical for Oral Delivery
Application:
60/940,598 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 23, 2006
From: MILLER, DUNCAN A.; MEHTA, NOZER M.; CONSALVO, ANGELO P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 018195/0030 →
Release of Security Interest
Jul 13, 2007
From: LEVY, JAY
To: UNIGENE LABORATORIES, INC.
Reel/Frame 019550/0483 →
Assignment of Security Interest
Sep 28, 2007
From: LEVY, JAY
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019892/0459 →
Amended and Restated Patent Security Agreement
Oct 11, 2007
From: UNIGENE LABORATORIES, INC.
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019943/0714 →
Release of Security Interest
Oct 1, 2008
From: OLYMPUS SECURITIES, LTD.; NELSON PARTNERS, CITADEL INVESTMENT MANAGEMENT, L.P., CITADEL INVESTMENT MANAGEMENT, INC.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 021603/0790 →
Security Agreement
Oct 3, 2008
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 021630/0352 →
Assignment of Assignor's Interest
Sep 12, 2012
From: STERN, WILLIAM
To: UNIGENE LABORATORIES INC.
Reel/Frame 028947/0938 →
Security Agreement
Oct 4, 2012
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT
Reel/Frame 029074/0689 →
Assignment of Assignor's Interest
Apr 26, 2013
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 030300/0538 →
Assignment of Assignor's Interest
Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
Assignment of Assignor's Interest
Sep 11, 2013
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 031185/0455 →
Assignment of Assignor's Interest
Mar 13, 2014
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 032434/0534 →
Assignment of Assignor's Interest
Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0281 →
Assignment of Assignor's Interest
Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0418 →
Assignment of Assignor's Interest
Mar 13, 2014
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 032434/0431 →
Assignment of Assignor's Interest
Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0733 →
Assignment of Assignor's Interest
Mar 17, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032457/0801 →
Assignment of Assignor's Interest
Jul 18, 2016
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 039182/0406 →
Assignment of Assignor's Interest
Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 039184 Frame 0797. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment Effective 02/01/2016.
Aug 15, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039682/0212 →
Release of Security Interest
Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0799 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →